Press Releases

Press Releases

March 1, 2018
CytomX to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. , March 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that the company’s management will participate in two upcoming investor
Displaying 11 - 12 of 12